Ipamorelin / CJC 1295 with/No DAC Pre-mixed Pen Combo 5mg + 2mg

£100.00

Ipamorelin / CJC-1295 with DAC Pre-mixed Pen Combo 5mg Ipamorelin + 2mg CJC-1295 with DAC

This pre-mixed research peptide pen combines two synergistic growth hormone secretagogues in a convenient ready-to-use format.

Composition per Pen:

  • Ipamorelin – 5 mg

  • CJC-1295 with DAC – 2 mg

Total Peptide Content: 7 mg

Mechanism of Action:

  • Ipamorelin: A selective ghrelin receptor (GHSR-1a) agonist that stimulates pulsatile growth hormone release with minimal impact on cortisol, prolactin, or hunger.

  • CJC-1295 with DAC: A long-acting Growth Hormone-Releasing Hormone (GHRH) analog that extends the duration of GH pulses through its Drug Affinity Complex (DAC) modification, providing sustained elevation of GH and IGF-1 levels.

Synergistic Benefits in Research: The combination of Ipamorelin and CJC-1295 with DAC is widely studied for its ability to produce amplified, sustained, and more natural pulsatile GH release compared to either peptide alone. This stack is commonly used in laboratory research investigating:

  • Enhanced growth hormone secretion and IGF-1 levels

  • Muscle growth, recovery, and body composition

  • Fat metabolism and lipolysis

  • Sleep quality and recovery

  • Anti-aging and regenerative protocols

Intended for laboratory research use only. Not for human or veterinary use.

Variant:

Ipamorelin / CJC-1295 with DAC Pre-mixed Pen Combo 5mg Ipamorelin + 2mg CJC-1295 with DAC

This pre-mixed research peptide pen combines two synergistic growth hormone secretagogues in a convenient ready-to-use format.

Composition per Pen:

  • Ipamorelin – 5 mg

  • CJC-1295 with DAC – 2 mg

Total Peptide Content: 7 mg

Mechanism of Action:

  • Ipamorelin: A selective ghrelin receptor (GHSR-1a) agonist that stimulates pulsatile growth hormone release with minimal impact on cortisol, prolactin, or hunger.

  • CJC-1295 with DAC: A long-acting Growth Hormone-Releasing Hormone (GHRH) analog that extends the duration of GH pulses through its Drug Affinity Complex (DAC) modification, providing sustained elevation of GH and IGF-1 levels.

Synergistic Benefits in Research: The combination of Ipamorelin and CJC-1295 with DAC is widely studied for its ability to produce amplified, sustained, and more natural pulsatile GH release compared to either peptide alone. This stack is commonly used in laboratory research investigating:

  • Enhanced growth hormone secretion and IGF-1 levels

  • Muscle growth, recovery, and body composition

  • Fat metabolism and lipolysis

  • Sleep quality and recovery

  • Anti-aging and regenerative protocols

Intended for laboratory research use only. Not for human or veterinary use.